Uncovering the genetic architecture of multiple sclerosis

Federica Esposito, Philip L. De Jager

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Multiple sclerosis (MS) is a disease in which genetic, environmental, and stochastic factors interact to trigger an inflammatory disease of the CNS that also has a neurodegenerative component. Over the past 3 years, progress in high-throughput technologies and analysis methods has synergized with the collaborative efforts of investigators studyingMS genetics to enable the discovery ofmore than a dozen genes involved in making individuals susceptible toMS. These genes are beginning to suggest molecular pathways that may be particularly vulnerable to genetic variation in MS. Soon, a comprehensivemap of common genetic variants affectingMSsusceptibilitywill be assembled, and communal efforts will need to focus on the more challenging issue of understanding the genetic architecture of disease course and treatment response in MS. Early efforts integrating different dimensions of information, including genomics, imaging, transcriptomics, and proteomics, with precise phenotypic data from clinicians illustrate the way forward for prognostic algorithms in MS and suggest that these approaches will yield a new series of insights in the next decade.

Original languageEnglish
Pages (from-to)147-165
Number of pages19
JournalCONTINUUM Lifelong Learning in Neurology
Volume16
Issue number5
DOIs
Publication statusPublished - Oct 2010

Fingerprint

Multiple Sclerosis
Inborn Genetic Diseases
Central Nervous System Diseases
Genomics
Proteomics
Genes
Research Personnel
Technology

ASJC Scopus subject areas

  • Clinical Neurology
  • Genetics(clinical)

Cite this

Uncovering the genetic architecture of multiple sclerosis. / Esposito, Federica; De Jager, Philip L.

In: CONTINUUM Lifelong Learning in Neurology, Vol. 16, No. 5, 10.2010, p. 147-165.

Research output: Contribution to journalArticle

@article{99451904fbd348889e1e360ec18927f1,
title = "Uncovering the genetic architecture of multiple sclerosis",
abstract = "Multiple sclerosis (MS) is a disease in which genetic, environmental, and stochastic factors interact to trigger an inflammatory disease of the CNS that also has a neurodegenerative component. Over the past 3 years, progress in high-throughput technologies and analysis methods has synergized with the collaborative efforts of investigators studyingMS genetics to enable the discovery ofmore than a dozen genes involved in making individuals susceptible toMS. These genes are beginning to suggest molecular pathways that may be particularly vulnerable to genetic variation in MS. Soon, a comprehensivemap of common genetic variants affectingMSsusceptibilitywill be assembled, and communal efforts will need to focus on the more challenging issue of understanding the genetic architecture of disease course and treatment response in MS. Early efforts integrating different dimensions of information, including genomics, imaging, transcriptomics, and proteomics, with precise phenotypic data from clinicians illustrate the way forward for prognostic algorithms in MS and suggest that these approaches will yield a new series of insights in the next decade.",
author = "Federica Esposito and {De Jager}, {Philip L.}",
year = "2010",
month = "10",
doi = "10.1212/01.CON.0000389939.15155.eb",
language = "English",
volume = "16",
pages = "147--165",
journal = "CONTINUUM Lifelong Learning in Neurology",
issn = "1080-2371",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Uncovering the genetic architecture of multiple sclerosis

AU - Esposito, Federica

AU - De Jager, Philip L.

PY - 2010/10

Y1 - 2010/10

N2 - Multiple sclerosis (MS) is a disease in which genetic, environmental, and stochastic factors interact to trigger an inflammatory disease of the CNS that also has a neurodegenerative component. Over the past 3 years, progress in high-throughput technologies and analysis methods has synergized with the collaborative efforts of investigators studyingMS genetics to enable the discovery ofmore than a dozen genes involved in making individuals susceptible toMS. These genes are beginning to suggest molecular pathways that may be particularly vulnerable to genetic variation in MS. Soon, a comprehensivemap of common genetic variants affectingMSsusceptibilitywill be assembled, and communal efforts will need to focus on the more challenging issue of understanding the genetic architecture of disease course and treatment response in MS. Early efforts integrating different dimensions of information, including genomics, imaging, transcriptomics, and proteomics, with precise phenotypic data from clinicians illustrate the way forward for prognostic algorithms in MS and suggest that these approaches will yield a new series of insights in the next decade.

AB - Multiple sclerosis (MS) is a disease in which genetic, environmental, and stochastic factors interact to trigger an inflammatory disease of the CNS that also has a neurodegenerative component. Over the past 3 years, progress in high-throughput technologies and analysis methods has synergized with the collaborative efforts of investigators studyingMS genetics to enable the discovery ofmore than a dozen genes involved in making individuals susceptible toMS. These genes are beginning to suggest molecular pathways that may be particularly vulnerable to genetic variation in MS. Soon, a comprehensivemap of common genetic variants affectingMSsusceptibilitywill be assembled, and communal efforts will need to focus on the more challenging issue of understanding the genetic architecture of disease course and treatment response in MS. Early efforts integrating different dimensions of information, including genomics, imaging, transcriptomics, and proteomics, with precise phenotypic data from clinicians illustrate the way forward for prognostic algorithms in MS and suggest that these approaches will yield a new series of insights in the next decade.

UR - http://www.scopus.com/inward/record.url?scp=78650744485&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650744485&partnerID=8YFLogxK

U2 - 10.1212/01.CON.0000389939.15155.eb

DO - 10.1212/01.CON.0000389939.15155.eb

M3 - Article

VL - 16

SP - 147

EP - 165

JO - CONTINUUM Lifelong Learning in Neurology

JF - CONTINUUM Lifelong Learning in Neurology

SN - 1080-2371

IS - 5

ER -